Author: jaredwhitis

 NuvOx Pharma has been issued US Patent No. 11,304,899, entitled “Compositions of fluorocarbon nanoemulsion, and methods of preparation and use thereof.” Evan Unger, MD, President and CEO of NuvOx, an inventor on the patent said, “We are pleased to receive this patent. This patent contains composition of matter claims covering perfluorohexane emulsions that can be used for oxygen-based therapeutics. Our current clinical programs are based on dodecafluoropentane emulsion (DDFPe, aka NanO2TM). Issuance of this patent covers another active pharmaceutical formulation which is useful for developing other products.” Nina Ossanna, PhD, Senior VP of Strategy for NuvOx, said, “Award of this ... Read more